P OSTER A BSTRACTS B159 Accuracy of Formulas to Predict Resting Metabolic Rate in Elderly Admitted to a Recuperative Care Unit. D. H. Sullivan, 1,2 K. P. Padala, 1,2 K. K. Garner, 1,2 R. A. Dennis, 1,2 M. Bopp, 1,2 P. R. Padala. 1,2 1. Geriatric Research Education and Clinical Center, VISN16/CAVHS, North Little Rock, AR; 2. <strong>Geriatrics</strong>, University of Arkansas for Medical Sciences, Little Rock, AR. Supported By: VA Health Services and Clinical Science Research and Development programs (HSR&D IIR-04-298 and CSR&D) and a University of Arkansas for Medical Sciences Tobacco Settlement award Background: There is a lack of validation studies of formulas for estimating resting metabolic rate (RMR) in elderly patients in the recuperative phase of illness. Given the importance of such formulas for estimating the nutrient requirements of older medically complex patients, this study was undertaken to explore this issue. Methods: This prospective study included 156 males over 64 years of age admitted to a recuperative care and rehabilitation unit located within a Veterans Affairs hospital Community Living Center. RMR was measured (mRMR) within seven days after admission by indirect calorimetry in the fasted state prior to the subjects’ arising in the morning. Height and weight were measured at the same time. Results: The subjects had a mean age of 79 + 8 years and 85% were white. Although free of metastatic cancer and other terminal conditions, all were deconditioned and most were undernourished and frail. For all 10 published formulas evaluated, estimated RMR (eRMR) was highly correlated with mRMR (r = 0.70 to 0.74, p
P OSTER A BSTRACTS a different strategy than young adults to deal with a walking challenge may potentially inform interventions to improve motor skill in walking. B162 Dual-Stiffness Flooring: Does it Reduce Fracture Rates Among Older Fallers ? F. Knoefel, 1 L. Patrick, 1 J. Taylor, 1 R. Goubran. 2,1 1. EBRI Research Institute, Ottawa, ON, Canada; 2. Engineering and Design, Carleton University, Ottawa, ON, Canada. Supported By: Satech Inc., Chehalis, WA, USA BACKGROUND: Fractures in older adults are associated with significant morbidity and mortality. Falls in this population lead to fractures approximately once every 20 falls. A number of bio-mechanical studies suggest that dual-stiffness flooring (DSF) diminishes the impact of contact with a floor, potentially reducing injuries associated with falls. To our knowledge however, there has never been a controlled study comparing fracture rates on regular flooring to that on DSF. METHODS: Mountain View Manor is a Skilled Nursing Facility in Prescott, Arizona where two resident bedrooms have DSF flooring (SmartCells flooring). Falls and related injuries were tracked during the period of July 1, 2008 to December 31, 2010. Injury rate comparisons, based on Chi-Square analyses, and prediction of room type allocation based on the number of injuries sustained, using Logistic Regression, were conducted. RESULTS: A total of 167 falls were reviewed. Fifty-five percent (55%) of falls resulted in an injury and 26% in a significant injury, defined as abrasion, cut, fracture or two or more injuries. There were 82 falls on the DSF and 85 falls on the regular floor. Patients in the dual-stiffness flooring rooms were significantly younger and took significantly fewer medications; these factors were thus treated as covariates in the analyses. There was a marked tendency for residents falling on DSF to have less bruising and abrasions, while having more redness and cuts. There were two fractures on regular flooring (2.4% fracture rate) and none on the DSF flooring (0% fracture rate). DISCUSSION: A 2.4% fracture rate (as noted on the regular floor) is consistent with numerous incidence reports in the literature; whereas a 0% rate (as noted on Smart- Cells DSF floor) is a clinically significant improvement over prior reported results. Both clinical findings and preliminary statistical trends analysis suggest a positive effect of dual-stiffness flooring. This suggests that DSF may be a practical approach for institutions and consumers to reduce fall-related injuries. In contrast to other solutions, like hip protectors, DSF requires no active client participation. A large scale study to achieve sufficient statistical power to statistically confirm these preliminary findings is warranted. B163 Subcortical Hyperintensities and Outcomes of Targeted Gait Interventions for Mobility Impairment. N. K. Nadkarni, S. Perera, J. Brach, H. Aizenstein, C. Rosano, S. A. Studenski, J. M. Van Swearingen. University of Pittsburgh, Pittsburgh, PA. Supported By: Source of funding: Pittsburgh Claude D. Pepper Older <strong>American</strong>’s Independence Center grant (P30 AG024827) Background: Gait interventions that incorporate motor-skill acquisition are superior to standard therapy in improving mobility impairment in elderly. Subcortical hyperintensities (SH), commonly seen on brain MRI of older adults, are associated with impairments in gait and executive function. Objective: We examined whether regional SH volumes influence gait outcomes from two types of gait interventions. Methods: We analyzed data from a 12 week randomized trial of community-dwelling older adults with mobility impairment receiving two interventions: progressive strength, balance and endurance training (I) vs goal-directed motor learning, adaptive stepping, pattern walking and dual-tasking (M). A linear model was used to study the relationship between pre- to post-intervention change in outcomes (gait speed, double-support time, step-time, stance time variability) with baseline SH in regions associated with executive function (anterior prefrontal cortex (APC), dorsolateral prefrontal cortex (DLPFC), ventrolateral prefrontal cortex (VLPFC), anterior cingulate (AC), basal ganglia and posterior parietal cortex). Results: Significant interactions emerged between right APC SH and intervention on changes in gait speed (p=0.04), step-time (p=0.001) and double-support time (p=0.01). With respect to steptime change, significant interactions emerged for SH in left APC (p=0.02), right and left DLPFC (p=0.03 and 0.02), right VLPFC (p=0.04) and right AC (p=0.02) with intervention. In the I-group, greater right APC and right AC SH were associated with poorer changes in gait speed (p=0.005 and 0.02), double support time (p=0.002 and 0.001), step-time (p=0.002 and 0.001) and variability in stance-time (p=0.004 and 0.01). In the M-group, there were no significant associations between changes in outcomes and SH in any of the above brain regions. Conclusion: Gait interventions that incorporate motor-skill acquisition and dual-tasking may benefit older adults irrespective of SH severity in brain regions linked to executive function while benefits from impairment-based interventions may depend on SH burden in these regions. B164 Mood and Neurocognitive Measures to Predict Intake and Function in Elderly in a Recuperative Care Unit. P. R. Padala, 1,3 P. Dubbert, 1,3 K. P. Padala, 1,2 K. Garner, 1,2 R. A. Dennis, 1,2 M. Bopp, 1,2 D. H. Sullivan. 1,2 1. Geriatric Research Education and Clinical Center, VISN16/CAVHS, North Little Rock, AR; 2. <strong>Geriatrics</strong>, University of Arkansas for Medical Sciences, Little Rock, AR; 3. Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR. Supported By: VA Health Services and Clinical Science Research and Development programs (HSR&D IIR-04-298 and CSR&D) and a University of Arkansas for Medical Sciences Tobacco Settlement award Background: Among older patients hospitalized for recuperative care and rehabilitation, persistent anorexia and poor functional rehabilitation are associated with high levels of inflammatory markers and other indicators of illness severity at admission. It is not known whether cognitive dysfunction or depression also contribute to the persistent anorexia and poor functional outcomes. Methods: This prospective study included patients over 64 years admitted to a recuperative care and rehabilitation unit in a VA hospital Community Living Center. Each subject’s daily total nutrient intake from all sources was measured using a standardized protocol. Depression was measured by the Geriatric Depression Scale-15 items (GDS), apathy was derived from 3 items on the GDS related to motivation (GDS-apathy), and executive function was measured by verbal fluency, digit span and Florida praxis battery. Correlation analyses were performed between the dependent variables of energy and protein intake with independent variables of mood and neurocognitive measures followed by regression analyses. T-tests were performed on the neurocognitive measures based on if the subjects were apathetic or not. Results: 416 veterans were enrolled. Mean scores at baseline were 3.7 (± 2.7) for GDS, 1.5 (±0.9) for GDS-apathy, 5.9 (±3.7) for Verbal Fluency-F, 7.4 (±2.5) for Digit Span Forward, 4.6 (±2.2) for Digit Span Backwards, 14.6 (±1.4) for Florida Praxis Battery, 83.8 (±35.7) and 59.7 (±23.6)for Average Energy and Protein Intake respectively. Baseline measures of apathy, depression, executive function did not predict either energy or protein intake. However baseline AGS 2012 ANNUAL MEETING S129
- Page 1:
Dear Annual Meeting Attendee: The A
- Page 8 and 9:
P APER A BSTRACTS the National Deat
- Page 10 and 11:
P APER A BSTRACTS two counts were u
- Page 12 and 13:
P APER A BSTRACTS management in col
- Page 14 and 15:
P APER A BSTRACTS control collagen
- Page 16 and 17:
P APER A BSTRACTS creating a barrie
- Page 18 and 19:
P APER A BSTRACTS Conclusion: This
- Page 20 and 21:
P APER A BSTRACTS rates for CRs wer
- Page 22 and 23:
P APER A BSTRACTS each definition
- Page 24 and 25:
P OSTER A BSTRACTS been ruled out.
- Page 26 and 27:
P OSTER A BSTRACTS Discussion: Angi
- Page 28 and 29:
P OSTER A BSTRACTS calcitriol via 1
- Page 30 and 31:
P OSTER A BSTRACTS ii J Clin Micrbi
- Page 32 and 33:
P OSTER A BSTRACTS is on the rise.
- Page 34 and 35:
P OSTER A BSTRACTS edema (60%), and
- Page 36 and 37:
P OSTER A BSTRACTS categories based
- Page 38 and 39:
P OSTER A BSTRACTS Methods: A longi
- Page 40 and 41:
P OSTER A BSTRACTS Design. CaMos is
- Page 42 and 43:
P OSTER A BSTRACTS incidents (64%)
- Page 44 and 45:
P OSTER A BSTRACTS TNF-R1 levels we
- Page 46 and 47:
P OSTER A BSTRACTS curriculum betwe
- Page 48 and 49:
P OSTER A BSTRACTS A75 Geriatrics a
- Page 50 and 51:
P OSTER A BSTRACTS Design: Based on
- Page 52 and 53:
P OSTER A BSTRACTS medicine fellows
- Page 54 and 55:
P OSTER A BSTRACTS While we were no
- Page 56 and 57:
P OSTER A BSTRACTS and knowledge pr
- Page 58 and 59:
P OSTER A BSTRACTS made more eye co
- Page 60 and 61:
P OSTER A BSTRACTS This study’s p
- Page 62 and 63:
P OSTER A BSTRACTS that a substanti
- Page 64 and 65:
P OSTER A BSTRACTS articulate goals
- Page 66 and 67:
P OSTER A BSTRACTS transitions invo
- Page 68 and 69:
P OSTER A BSTRACTS findings suggest
- Page 70 and 71:
P OSTER A BSTRACTS and its sum of b
- Page 72 and 73:
P OSTER A BSTRACTS NTM infection wa
- Page 74 and 75:
P OSTER A BSTRACTS death because
- Page 76 and 77:
P OSTER A BSTRACTS A158 Curved Path
- Page 78 and 79:
P OSTER A BSTRACTS compared to pati
- Page 80 and 81:
P OSTER A BSTRACTS Methods: We are
- Page 82 and 83:
P OSTER A BSTRACTS with only about
- Page 84 and 85: P OSTER A BSTRACTS with typical ris
- Page 86 and 87: P OSTER A BSTRACTS The aim of this
- Page 88 and 89: P OSTER A BSTRACTS B27 Shared Decis
- Page 90 and 91: P OSTER A BSTRACTS SES, adiposity a
- Page 92 and 93: P OSTER A BSTRACTS care (OR 1.93, 9
- Page 94 and 95: P OSTER A BSTRACTS Conclusion: Agin
- Page 96 and 97: P OSTER A BSTRACTS B49 Prevalence a
- Page 98 and 99: P OSTER A BSTRACTS Conclusions: The
- Page 100 and 101: P OSTER A BSTRACTS B61 Losartan inc
- Page 102 and 103: P OSTER A BSTRACTS Conclusions Our
- Page 104 and 105: P OSTER A BSTRACTS Significant incr
- Page 106 and 107: P OSTER A BSTRACTS frailty have inc
- Page 108 and 109: P OSTER A BSTRACTS Conclusion: In t
- Page 110 and 111: P OSTER A BSTRACTS BMI=28.4, mean P
- Page 112 and 113: P OSTER A BSTRACTS Each subject’s
- Page 114 and 115: P OSTER A BSTRACTS There is growing
- Page 116 and 117: P OSTER A BSTRACTS variation in uti
- Page 118 and 119: P OSTER A BSTRACTS complex elders s
- Page 120 and 121: P OSTER A BSTRACTS satisfaction wit
- Page 122 and 123: P OSTER A BSTRACTS Methods: The Hon
- Page 124 and 125: P OSTER A BSTRACTS B130 Early Disco
- Page 126 and 127: P OSTER A BSTRACTS IgE antibodies i
- Page 128 and 129: P OSTER A BSTRACTS contribution by
- Page 130 and 131: P OSTER A BSTRACTS The oldest old (
- Page 132 and 133: P OSTER A BSTRACTS B153 Encore Pres
- Page 136 and 137: P OSTER A BSTRACTS GDS and GDS apat
- Page 138 and 139: P OSTER A BSTRACTS status, procedur
- Page 140 and 141: P OSTER A BSTRACTS In this case it
- Page 142 and 143: P OSTER A BSTRACTS the episodes of
- Page 144 and 145: P OSTER A BSTRACTS paralysis is see
- Page 146 and 147: P OSTER A BSTRACTS grip strength ch
- Page 148 and 149: P OSTER A BSTRACTS Discussion/Concl
- Page 150 and 151: P OSTER A BSTRACTS Results: Of 1401
- Page 152 and 153: P OSTER A BSTRACTS Results: Regiona
- Page 154 and 155: P OSTER A BSTRACTS Conclusions: Con
- Page 156 and 157: P OSTER A BSTRACTS 2.47-25.96), and
- Page 158 and 159: P OSTER A BSTRACTS Methods: EMR ACP
- Page 160 and 161: P OSTER A BSTRACTS patient populati
- Page 162 and 163: P OSTER A BSTRACTS C71 Outpatient A
- Page 164 and 165: P OSTER A BSTRACTS IPE are generall
- Page 166 and 167: P OSTER A BSTRACTS the outpatient s
- Page 168 and 169: P OSTER A BSTRACTS 0.03). Age and s
- Page 170 and 171: P OSTER A BSTRACTS C94 Exploring th
- Page 172 and 173: P OSTER A BSTRACTS with the least e
- Page 174 and 175: P OSTER A BSTRACTS physician resist
- Page 176 and 177: P OSTER A BSTRACTS Table 1. Effect
- Page 178 and 179: P OSTER A BSTRACTS C118 Patient and
- Page 180 and 181: P OSTER A BSTRACTS We monitor the t
- Page 182 and 183: P OSTER A BSTRACTS PROGRAM STRUCTUR
- Page 184 and 185:
P OSTER A BSTRACTS C135 Encore Pres
- Page 186 and 187:
P OSTER A BSTRACTS C141 Contributio
- Page 188 and 189:
P OSTER A BSTRACTS nal process can
- Page 190 and 191:
P OSTER A BSTRACTS project, we atte
- Page 192 and 193:
P OSTER A BSTRACTS Methods: Two hun
- Page 194 and 195:
P OSTER A BSTRACTS Case: A 78 year-
- Page 196 and 197:
P OSTER A BSTRACTS two synergistic
- Page 198 and 199:
P OSTER A BSTRACTS then awoke spont
- Page 200 and 201:
P OSTER A BSTRACTS cancer, non mali
- Page 202 and 203:
P OSTER A BSTRACTS The diagnosis of
- Page 204 and 205:
P OSTER A BSTRACTS D32 Comparison o
- Page 206 and 207:
P OSTER A BSTRACTS D38 The burden o
- Page 208 and 209:
P OSTER A BSTRACTS rate was 21.9% f
- Page 210 and 211:
P OSTER A BSTRACTS D50 A Pilot Stud
- Page 212 and 213:
P OSTER A BSTRACTS of the education
- Page 214 and 215:
P OSTER A BSTRACTS and geriatrics c
- Page 216 and 217:
P OSTER A BSTRACTS Care Surgery, Em
- Page 218 and 219:
P OSTER A BSTRACTS survey using the
- Page 220 and 221:
P OSTER A BSTRACTS & Go Test, and T
- Page 222 and 223:
P OSTER A BSTRACTS binge drinking d
- Page 224 and 225:
P OSTER A BSTRACTS The percentages
- Page 226 and 227:
P OSTER A BSTRACTS other forms of t
- Page 228 and 229:
P OSTER A BSTRACTS D102 Clinician
- Page 230 and 231:
P OSTER A BSTRACTS this result repr
- Page 232 and 233:
P OSTER A BSTRACTS D114 Fall Reduct
- Page 234 and 235:
P OSTER A BSTRACTS D120 Geropsychia
- Page 236 and 237:
P OSTER A BSTRACTS In addition to 7
- Page 238 and 239:
P OSTER A BSTRACTS D132 Encore Pres
- Page 240 and 241:
P OSTER A BSTRACTS Conclusions: The
- Page 242 and 243:
P OSTER A BSTRACTS D144 The Use of
- Page 244 and 245:
P OSTER A BSTRACTS Methods: Cross-s
- Page 246 and 247:
P OSTER A BSTRACTS CONCLUSIONS: The
- Page 248 and 249:
P OSTER A BSTRACTS Aggressive treat
- Page 250 and 251:
A UTHOR I NDEX Azhar, G . . . . . .
- Page 252 and 253:
A UTHOR I NDEX Ceimo, J . . . . . .
- Page 254 and 255:
A UTHOR I NDEX Dunn, C M . . . . .
- Page 256 and 257:
A UTHOR I NDEX Griebling, T L . . .
- Page 258 and 259:
A UTHOR I NDEX Johnson, K . . . . .
- Page 260 and 261:
A UTHOR I NDEX Levine, M . . . . .
- Page 262 and 263:
A UTHOR I NDEX Mulsant, B . . . . .
- Page 264 and 265:
A UTHOR I NDEX Pschirer, J P . . .
- Page 266 and 267:
A UTHOR I NDEX Sheppard, K D . . .
- Page 268 and 269:
A UTHOR I NDEX Ukritchon, S . . . .
- Page 270 and 271:
K EYWORD 25-hydroxyvitamin D . . .
- Page 272 and 273:
K EYWORD I NDEX Colorectal cancer s
- Page 274 and 275:
K EYWORD I NDEX Geriatric curriculu
- Page 276 and 277:
K EYWORD I NDEX Medication discrepa
- Page 278 and 279:
K EYWORD I NDEX Race . . . . . . .
- Page 280:
This page intentionally left blank